Interchange Capital Partners »

Recursion Pharmaceuticals shares owned by Interchange Capital Partners

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Interchange Capital Partners from 13F filings

Historical chart of Interchange Capital Partners investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Interchange Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Interchange Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $224k 23k 9.83

More positions owned by Interchange Capital Partners

Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Value (VLUE)
Ishares Core Msci Emkt (IEMG)
Apple (AAPL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Betabuldrs Japan (BBJP)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Amazon (AMZN)
Ishares Msci Eurzone Etf (EZU)

View all positions for Interchange Capital Partners

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
MIC Capital Management UK
Nvidia Corp
Norges Bank Investment Management
Dimensional Fund Advisors
Credit Suisse
Point72 Asset Management
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Recursion Pharmaceuticals